Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice
J Antimicrob Chemother
.
2019 May 1;74(5):1461-1463.
doi: 10.1093/jac/dkz009.
Authors
Gianmaria Baldin
1
,
Arturo Ciccullo
1
,
Alberto Borghetti
2
,
Simona Di Giambenedetto
1
2
Affiliations
1
Institute of Clinical Infectious Diseases, Catholic University of the Sacred Heart, Rome, Italy.
2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
PMID:
30726922
DOI:
10.1093/jac/dkz009
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-HIV Agents*
HIV-1*
Heterocyclic Compounds, 3-Ring
Lamivudine
Oxazines
Piperazines
Pyridones
Substances
Anti-HIV Agents
Heterocyclic Compounds, 3-Ring
Oxazines
Piperazines
Pyridones
Lamivudine
dolutegravir